Sameer Sabir
Co-Founder & CEO
Brixton Biosciences
Bio:
Sameer Sabir is the Co-Founder & CEO of Brixton Biosciences, a venture-backed life sciences company. Previously, Sameer was the Co-Founder & CEO of SevenOaks Biosystems, a venture-backed medical device company acquired by Medline Industries in 2016.
Prior to SevenOaks, Sameer was the Co-Founder and CEO of MoMelan Technologies, a venture-backed medical device company acquired by Acelity, Inc in 2012.
Sameer is a graduate of the Harvard-MIT Biomedical Enterprise Program and holds an MBA from the Sloan School of Management at MIT, an SM from the Harvard-MIT Division of Health Sciences and Technology, and a B.Sc from University College London.